Global epileptic anticonvulsants market - 2014-2020

16 July 2014

North America dominates the global epileptic anticonvulsants market and is followed by Europe, according to a new report from Transparency Market Research titled Epileptic Anticonvulsants Market.

Factors such as highly developed health care infrastructure, high health care spending, high rate of awareness about epilepsy and related treatments and availability of skilled health care professionals to treat epilepsy are driving North American epileptic anticonvulsants market towards growth. Asia-Pacific is a lucrative region for epileptic anticonvulsants.

Some of the factors such as increasing health care spending, rapidly improving health care infrastructure and increasing government initiatives to offer improved health care facilities on the ground of rapidly growing medical tourism industry in this region are likely to fuel the growth of epileptic anticonvulsants market.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK